| 0.802 | 0.005 | 0.802 | Toll-Like receptor 7 agonist | | |
| 0.799 | 0.005 | 0.799 | Toll-Like receptor agonist | | |
| 0.713 | 0.001 | 0.713 | Adrenaline agonist | | |
| 0.582 | 0.001 | 0.582 | Beta adrenoreceptor agonist | | |
| 0.583 | 0.004 | 0.583 | Bronchodilator | | |
| 0.591 | 0.014 | 0.591 | Spasmolytic | | |
| 0.576 | 0.009 | 0.576 | Calcium channel L-type activator | | |
| 0.552 | 0.001 | 0.552 | Beta 1 adrenoreceptor agonist | | |
| 0.543 | 0.002 | 0.543 | Beta 2 adrenoreceptor antagonist | | |
| 0.493 | 0.002 | 0.493 | Beta adrenoreceptor antagonist | | |
| 0.453 | 0.004 | 0.453 | Acetylcholine M1 receptor antagonist | | |
| 0.442 | 0.006 | 0.442 | Acetylcholine antagonist | | |
| 0.441 | 0.006 | 0.441 | Cholinergic antagonist | | |
| 0.428 | 0.004 | 0.428 | Acetylcholine muscarinic antagonist | | |
| 0.412 | 0.001 | 0.412 | Beta 2 adrenoreceptor agonist | | |
| 0.412 | 0.002 | 0.412 | Beta 3 adrenoreceptor antagonist | | |
| 0.415 | 0.008 | 0.415 | Antiadrenergic | | |
| 0.412 | 0.008 | 0.412 | Adrenaline antagonist | | |
| 0.407 | 0.003 | 0.407 | Acetylcholine M3 receptor antagonist | | |
| 0.427 | 0.056 | 0.427 | Antiobesity | | |
| 0.416 | 0.05 | 0.416 | Vasodilator, peripheral | | |
| 0.43 | 0.075 | 0.43 | Cyclophilin D inhibitor | | |
| 0.305 | 0.003 | 0.305 | Beta 1 adrenoreceptor antagonist | | |
| 0.292 | 0.003 | 0.292 | Acetylcholine M5 receptor antagonist | | |
| 0.289 | 0.002 | 0.289 | Beta 3 adrenoreceptor agonist | | |
| 0.276 | 0.005 | 0.276 | Acetylcholine M2 receptor antagonist | | |
| 0.311 | 0.052 | 0.311 | Cardiotonic | | |
| 0.345 | 0.105 | 0.345 | Antibacterial | | |
| 0.324 | 0.14 | 0.324 | 5 Hydroxytryptamine release inhibitor | | |
| 0.234 | 0.065 | 0.234 | Psychostimulant | | |
| 0.177 | 0.018 | 0.177 | NMDA receptor antagonist | | |
| 0.229 | 0.075 | 0.229 | Cyclic AMP phosphodiesterase inhibitor | | |
| 0.173 | 0.021 | 0.173 | Antineoplastic alkaloid | | |
| 0.164 | 0.014 | 0.164 | NMDA 2 receptor antagonist | | |
| 0.211 | 0.071 | 0.211 | Nitric-oxide synthase stimulant | | |
| 0.21 | 0.087 | 0.21 | Peptidyltransferase inhibitor | | |
| 0.136 | 0.017 | 0.136 | Dopamine agonist | | |
| 0.125 | 0.008 | 0.125 | Dopamine D2 agonist | | |
| 0.162 | 0.062 | 0.162 | NOS3 expression enhancer | | |
| 0.111 | 0.013 | 0.111 | NMDA 2C receptor antagonist | | |
| 0.232 | 0.14 | 0.232 | Interleukin 2 agonist | | |
| 0.225 | 0.156 | 0.225 | Sodium/bile acid cotransporter inhibitor | | |
| 0.082 | 0.025 | 0.082 | 5 Hydroxytryptamine 2A agonist | | |
| 0.205 | 0.171 | 0.205 | Antithrombotic | | |
| 0.082 | 0.049 | 0.082 | Somatostatin 1 agonist | | |
| 0.131 | 0.099 | 0.131 | Adenylate cyclase stimulant | | |
| 0.106 | 0.077 | 0.106 | Anesthetic local | | |
| 0.048 | 0.021 | 0.048 | Nicotinic acid receptor 1 agonist | | |
| 0.064 | 0.038 | 0.064 | Alpha 2 adrenoreceptor agonist | | |
| 0.065 | 0.042 | 0.065 | DNA gyrase inhibitor | | |
| 0.069 | 0.046 | 0.069 | Alpha adrenoreceptor agonist | | |
| 0.042 | 0.025 | 0.042 | Dopamine D3 agonist | | |
| 0.031 | 0.013 | 0.031 | DNA polymerase III inhibitor | | |
| 0.093 | 0.076 | 0.093 | Topoisomerase I inhibitor | | |
| 0.023 | 0.008 | 0.023 | Calcium-sensing receptor antagonist | | |
| 0.043 | 0.031 | 0.043 | NMDA receptor subunit 3B antagonist | | |
| 0.064 | 0.052 | 0.064 | Phenylalanine 4-hydroxylase inhibitor | | |
| 0.037 | 0.028 | 0.037 | NMDA receptor subunit 3A antagonist | | |
| 0.014 | 0.006 | 0.014 | DNA polymerase III polC-type inhibitor | | |
| 0.171 | 0.168 | 0.171 | DNA synthesis inhibitor | | |
| 0.154 | 0.151 | 0.154 | Vasodilator | | |
| 0.042 | 0.04 | 0.042 | Parathyroid hormone antagonist | | |
| 0.028 | 0.026 | 0.028 | DNA topoisomerase IV inhibitor | | |